Literature DB >> 15842046

EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.

C Cameron Yin1, L Jeffrey Medeiros, Lynne V Abruzzo, Dan Jones, Anwar I Farhood, Vilmos A Thomazy.   

Abstract

Posttransplant lymphoproliferative disorders (PTLDs) usually are of B-cell lineage and associated with Epstein-Barr virus (EBV). PTLDs of T-cell lineage are much less common and infrequently associated with EBV. We report a rare case of a girl in whom B-cell and T-cell PTLDs developed following 2 EBV-negative kidney transplants. Within 2 years of the second transplantation, the originally EBV-negative patient developed both an EBV-associated clonal B-cell PTLD involving lymph nodes and an EBV-positive T-cell PTLD involving bone marrow and liver. These proliferations occurred concurrently with evidence of primary EBV infection and high plasma viral load. The patient eventually died of multiorgan failure 5 years after the initial transplant (3 years after the second transplant). To our knowledge, only 4 cases of both B-cell and T-cell PTLDs have been reported. Only 2 cases have been proven to be monoclonal and EBV-associated, as in this case, the first following kidney transplantation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15842046

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Composite B-cell and T-cell lineage post-transplant lymphoproliferative disorder of the lung with unusual cutaneous manifestations of mycosis fungoides.

Authors:  Kyle C Mills; Omar P Sangüeza; Michael W Beaty; Mark Raffeld; Changlee S Pang
Journal:  Am J Dermatopathol       Date:  2012-04       Impact factor: 1.533

2.  Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.

Authors:  Fan Yang; Ying Li; Raul Braylan; Stephen P Hunger; Li-Jun Yang
Journal:  Pediatr Blood Cancer       Date:  2008-02       Impact factor: 3.167

3.  Successful treatment of central nervous system PTLD with rituximab and cranial radiotherapy.

Authors:  Valerie Said-Conti; Persis J Amrolia; Mark N Gaze; Sara Stoneham; Neil Sebire; Rukshana Shroff; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2013-06-07       Impact factor: 3.714

4.  Isolated post-transplantation lymphoproliferative disease involving the breast and axilla as peripheral T-cell lymphoma.

Authors:  Ji-Young Hwang; Eun Suk Cha; Jee Eun Lee; Sun Hee Sung
Journal:  Korean J Radiol       Date:  2013-08-30       Impact factor: 3.500

5.  Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Authors:  Mikiko Kobayashi; Naoko Asano; Mana Fukushima; Takayuki Honda
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

6.  The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?

Authors:  Mari Frances Kilner; Serena Merante; Alexandr Svec
Journal:  BMJ Case Rep       Date:  2013-12-16

7.  A Unique "Composite" PTLD with Diffuse Large B-Cell and T/Anaplastic Large Cell Lymphoma Components Occurring 17 Years after Transplant.

Authors:  Kristin La Fortune; Dahua Zhang; Gordana Raca; Erik A Ranheim
Journal:  Case Rep Hematol       Date:  2013-05-07

8.  Posttransplant lymphoproliferative disorders.

Authors:  Hazem A H Ibrahim; Kikkeri N Naresh
Journal:  Adv Hematol       Date:  2012-04-17

Review 9.  Role of the ubiquitin system and tumor viruses in AIDS-related cancer.

Authors:  Julia Shackelford; Joseph S Pagano
Journal:  BMC Biochem       Date:  2007-11-22       Impact factor: 4.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.